Opinion: Diagnostics Needed

Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.

A photograph of Mark Kessel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, PHR-ISRAELThe greatest obstacle to the care and control of diseases in the developing world is the absence of accurate and affordable diagnostic tests. This deficit can cause delayed diagnosis that lead to less effective and more expensive treatments, as well as the spread of disease to others. Worse, lack of sufficient diagnostics can result in misdiagnoses, improper treatment, and sometimes death. And even when diagnostics are available, they are often too costly, or at least more costly than the drugs to treat a perceived disease, further contributing to drug resistance. The net effect is endangered lives, wasted resources, and the potential to create an even bigger health problem.

There are many challenges to achieving a successful diagnostic. Being inexpensive alone is not sufficient. It also has to be able to perform to high standards in challenging settings, such as villages across much of Africa where a small percentage of health facilities have access to a reliable power supply or towns and villages in the Indian subcontinent where operating temperatures are regularly above 40°C. As a result, such tests have to be affordable, sensitive, specific, user-friendly, robust and rapid, equipment-free, and deliverable (ASSURED tests). Given all these challenges, developing new diagnostics for resource limited settings continues to be underfunded.

The potential to create inexpensive and effective diagnostic tests from a technological point of view should be achievable, however. For example multiple tests for malaria ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • A photograph of Mark Kessel

    Mark Kessel

    Mark Kessel is chairman of FIND, the global alliance for diagnostics.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo